Sanofi, GSK kick off Phase III trial for COVID-19 shot ...United Arab Emirates

Gulf News - News
Sanofi, GSK kick off Phase III trial for COVID-19 shot
France's Sanofi and Britain's GlaxoSmithKline launched a late-stage human trial for a recombinant COVID-19 vaccine candidate on Thursday which they hope to get approved by the end of 2021. The study initiated by Sanofi and GSK is one of the first late stage trials that combines tests for boosters and variants, as drugmakers adapt their strategies to deal with an evolving coronavirus. The two drugmakers, which earlier this month reported positive interim results, confirmed their double-blind, placebo-controlled, phase III study would include more than 35,000 adults in the United States, Asia, Africa, and Latin America. "In a two-stage approach, the study will initially investigate the effica

Hence then, the article about sanofi gsk kick off phase iii trial for covid 19 shot was published today ( ) and is available on Gulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sanofi, GSK kick off Phase III trial for COVID-19 shot )

Apple Storegoogle play

Last updated :

Also on site :